Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BTBD9 antibody (AA 200-400)

This Mouse Monoclonal antibody specifically detects BTBD9 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7864599
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for BTBD9 antibody (AA 200-400) (ABIN7864599)

Target

See all BTBD9 Antibodies
BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

Reactivity

  • 18
  • 2
  • 1
Human

Host

  • 12
  • 6
Mouse

Clonality

  • 15
  • 3
Monoclonal

Conjugate

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
This BTBD9 antibody is un-conjugated

Application

  • 16
  • 10
  • 9
  • 9
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

BTBD9-7501
  • Binding Specificity

    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 200-400

    Purpose

    BTBD9 Antibody

    Specificity

    BTBD9 (BTB/POZ domain-containing protein 9) is a 612 amino acid protein that contains one BTB/POZ domain and one BACK (BTB/Kelch associated) domain. The BTB/POZ domain mediates homomeric and heteromeric POZPOZ interactions and is common to transcriptional regulators involved in chromatin modeling. In several BTB/POZ containing proteins, including Bcl-6 and the promyelocytic leukemia zinc-finger (PLZF) oncoprotein, this domain interacts with the SMRT/N-CoR-mSin3A HDAC complex and is directly involved in repressing and silencing gene transcription. When this domain is deleted, as with the oncogenic PLZF-RAR chimera of promyelocytic leukemias, this transcriptional repression is attenuated. This suggests that BTBD9 may play a role in transcription regulation. Genetic variations in the gene that encodes BTBD9 have been associated with susceptibility to restless legs syndrome type 6 (RLS6), a condition characterized by an uncontrollable urge to move the legs while resting.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa200-400) of human BTBD9 protein (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

    Alternative Name

    BTBD9

    Background

    BTB/POZ domain-containing protein 9

    Human fallopian tube|lung or lymph node.

    Molecular Weight

    69kDa

    Gene ID

    114781, 603858

    UniProt

    Q96Q07

    Pathways

    Transition Metal Ion Homeostasis
You are here:
Chat with us!